Evolving Europe Principal Investments I and Morphosis Capital have invested in Medima, a Romanian medical imaging network, to capitalize on the growing demand for advanced diagnostic services.
Information on the Target
Medima is a leading national network of medical imaging clinics in Romania, specializing in advanced diagnostic services including MRI, CT, and PET-CT. Operating 17 state-of-the-art clinics, Medima is dedicated to providing patients with access to high-quality imaging studies using the latest technologies. The company emphasizes affordable pricing and minimal wait times, ensuring that patients receive timely medical interventions. The medical team is led by Professor Dr. Gheorghe Iana, a respected figure in Romanian radiology, who oversees a network of esteemed radiologists known for their expertise.
Industry Overview in Romania
The healthcare sector in Romania has been experiencing significant transformations in recent years, particularly in medical imaging. A growing emphasis on early diagnosis and preventative care has driven demand for advanced imaging services. Innovations in technology have enabled healthcare providers to offer more accurate diagnoses, which is crucial in a country where access to timely healthcare can be limited.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Additionally, increased investments from both public and private sectors are improving healthcare infrastructure. The Romanian government has initiated various reforms aimed at modernizing healthcar
Similar Deals
Morphosis Capital Fund II → Echo Elderly Care
2025
Accession Capital Partners → Medicales Servicii de Sanatate Premium SA
2023
The Rohatyn Group → Amethyst
2023
Morphosis Capital Fund I Cooperatief UA → Dr. Leahu Dental Clinics
2023
BlackPeak Capital → Affinity Life Care
Avenue Venture Opportunities Fund II, L.P. → Spruce Biosciences, Inc.
2026
Evolving Europe Principal Investments I
invested in
Medima
in 2022
in a Growth Equity & Expansion Capital deal